Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial. [electronic resource]
Producer: 20071015Description: 79-87 p. digitalISSN:- 0360-3016
- Aged
- Androgen Antagonists -- therapeutic use
- Antineoplastic Agents, Hormonal -- therapeutic use
- Black People
- Cytochrome P-450 CYP3A
- Cytochrome P-450 Enzyme System -- genetics
- Disease Progression
- Flutamide -- therapeutic use
- Genotype
- Goserelin -- therapeutic use
- Humans
- Male
- Neoplasm Proteins -- genetics
- Practice Guidelines as Topic
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- enzymology
- Regression Analysis
- Survival
- White People
- Black or African American
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.